Top Markets
Coin of the day
Apimeds Pharmaceuticals US, Inc Apimeds Pharmaceuticals US, Inc

Apimeds Pharmaceuticals US, Inc

APUS
Rang in aandelen #33687
Apimeds Pharmaceuticals US, Inc. (APUS) functions as a clinical-stage... Apimeds Pharmaceuticals US, Inc. (APUS) functions as a clinical-stage biopharmaceutical firm operating within the United States. This company is dedicated to the entire lifecycle of its flagship product, Apitox – from its initial investigation and development to its production, market introduction, and sales. Apitox, a key active pharmaceutical ingredient, is specifically designed to alleviate inflammation and manage pain symptoms experienced by individuals suffering from osteoarthritis and multiple sclerosis. Established in 2020, APUS has its corporate headquarters situated in Hopewell, New Jersey, and operates as a subsidiary of Api Meds, Inc.
Aandeelprijs
$4.70
Laatst gesynchroniseerd: 2026-08-14
Marktkapitalisatie
$7.09M
Verandering (1 dag)
-0.21%
Verandering (1 jaar)
-70.63%
Land
US
Handel Apimeds Pharmaceuticals US, Inc (APUS)

Categorie

Dividendrendementgeschiedenis voor Apimeds Pharmaceuticals US, Inc (APUS)
Het dividendrendement (TTM) van Apimeds Pharmaceuticals US, Inc (aandelsymbool: APUS) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Apimeds Pharmaceuticals US, Inc (APUS) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten